SEC
SlamSEC
SearchBrowseEarnings

KYNTRA BIO, INC.

Nasdaq:KYNB
Pharmaceutical Preparations·SAN FRANCISCO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1001 total)

TypeDateAccessionPeriodSize
4
Mar 10, 2026
0001815638-26-000003
Mar 6, 2026
5.4 KB
4
Mar 10, 2026
0002040705-26-000003
Mar 6, 2026
4.8 KB
SCHEDULE 13G/A
Feb 17, 2026
0001172661-26-001239
—
10.2 KB
4
Feb 5, 2026
0001815638-26-000002
Feb 3, 2026
5.3 KB
4
Feb 5, 2026
0002040705-26-000002
Feb 3, 2026
5.3 KB
8-K
Jan 7, 2026
0001193125-26-0063278-K
Jan 7, 2026
326.4 KB
4
Dec 9, 2025
0002040705-25-000002
Dec 6, 2025
4.7 KB
4
Dec 9, 2025
0001815638-25-000005
Dec 6, 2025
5.3 KB
4
Nov 17, 2025
0001815638-25-000004
Nov 13, 2025
6.6 KB
SCHEDULE 13G/A
Nov 14, 2025
0001172661-25-005176
—
10.4 KB
10-Q
Nov 10, 2025
0001193125-25-27424110-Q
Sep 30, 2025
12.1 MB
8-K
Nov 10, 2025
0001193125-25-2741928-K
Nov 10, 2025
459.8 KB
8-K
Nov 6, 2025
0001193125-25-2695298-K
Nov 6, 2025
145.1 KB
4
Sep 9, 2025
0001415889-25-024014
Jun 6, 2025
6.3 KB
4
Sep 9, 2025
0001415889-25-024012
Jun 6, 2025
6.9 KB
8-K
Sep 5, 2025
0000921299-25-0000078-K
Aug 29, 2025
512.9 KB
8-K
Sep 2, 2025
0000950170-25-1123418-K
Aug 29, 2025
177.9 KB
8-K
Aug 18, 2025
0000950170-25-1095718-K
Aug 18, 2025
167.1 KB
SCHEDULE 13G/A
Aug 15, 2025
0001172661-25-003627
—
10.4 KB
8-K
Aug 14, 2025
0000950170-25-1082808-K
Aug 12, 2025
216.2 KB
10-Q
Aug 11, 2025
0000950170-25-10654910-Q
Jun 30, 2025
11.1 MB
8-K
Aug 11, 2025
0000950170-25-1065348-K
Aug 11, 2025
456.5 KB
SCHEDULE 13G/A
Jul 29, 2025
0000932471-25-000725
—
6.0 KB
8-K
Jul 14, 2025
0000950170-25-0956288-K
Jul 14, 2025
219.3 KB
4
Jul 2, 2025
0001415889-25-019067
Jun 30, 2025
5.0 KB
25 filings shown

Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California.